We've found
184,457
clinical trials
Patient Discharge Clinical Trial
Remote Presence Timely Discharge Management
Status: Enrolling
Updated: 3/15/2007
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Status: Enrolling
Updated: 2/24/2010
Click here to add this to my saved trials
Chronic Diabetic Foot Ulcers Clinical Trial
Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers
Status: Enrolling,
Phase
II
Updated: 8/17/2006
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
Status: Enrolling,
Phase
IV
Updated: 8/29/2006
Click here to add this to my saved trials
Cardiovascular Disease Clinical Trial
Cardiology Biobank Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Other, Reproductive Clinical Trial
The Women's Urology Center/WISH Database Project
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer
Status: Enrolling
Updated: 6/14/2011
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients
Status: Enrolling
Updated: 9/20/2006
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Vulvar Cancer Clinical Trial
Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.
Status: Enrolling
Updated: 4/24/2013
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Acupuncture for the Treatment of Phantom Limb and Residual Limb Pain After Amputation
Status: Enrolling,
Phase
I
Updated: 6/5/2007
Click here to add this to my saved trials
Unruptured Brain Arteriovenous Malformation Clinical Trial
A Randomized Trial of Unruptured Brain AVMs
Status: Enrolling
Updated: 11/2/2012
Click here to add this to my saved trials
Unruptured Brain Arteriovenous Malformation Clinical Trial
A Randomized Trial of Unruptured Brain AVMs
Status: Enrolling
Updated: 11/2/2012
Click here to add this to my saved trials
Unruptured Brain Arteriovenous Malformation Clinical Trial
A Randomized Trial of Unruptured Brain AVMs
Status: Enrolling
Updated: 11/2/2012
Click here to add this to my saved trials
Unruptured Brain Arteriovenous Malformation Clinical Trial
A Randomized Trial of Unruptured Brain AVMs
Status: Enrolling
Updated: 11/2/2012
Click here to add this to my saved trials
Unruptured Brain Arteriovenous Malformation Clinical Trial
A Randomized Trial of Unruptured Brain AVMs
Status: Enrolling
Updated: 11/2/2012
Click here to add this to my saved trials
Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial
Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment
Status: Enrolling,
Phase
II
Updated: 1/9/2014
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Status: Enrolling
Updated: 4/9/2010
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer
Status: Enrolling
Updated: 7/22/2009
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders
Status: Enrolling
Updated: 3/23/2009
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Depression Screening in Patients With Lung Cancer
Status: Enrolling
Updated: 10/14/2010
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
Status: Enrolling,
Phase
II
Updated: 2/12/2007
Click here to add this to my saved trials
We've found
184,457
clinical trials
Patient Discharge Clinical Trial
Updated: 3/15/2007
Remote Presence Timely Discharge Management
Status: Enrolling
Updated: 3/15/2007
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 2/24/2010
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Status: Enrolling
Updated: 2/24/2010
Click here to add this to my saved trials
Chronic Diabetic Foot Ulcers Clinical Trial
Updated: 8/17/2006
Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers
Status: Enrolling,
Phase
II
Updated: 8/17/2006
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Updated: 8/29/2006
Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
Status: Enrolling,
Phase
IV
Updated: 8/29/2006
Click here to add this to my saved trials
Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Cardiology Biobank Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Other, Reproductive Clinical Trial
Updated: 12/31/1969
The Women's Urology Center/WISH Database Project
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 6/14/2011
Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer
Status: Enrolling
Updated: 6/14/2011
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Updated: 9/20/2006
Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients
Status: Enrolling
Updated: 9/20/2006
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 3/15/2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 3/15/2011
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 8/3/2012
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Status: Enrolling
Updated: 8/3/2012
Click here to add this to my saved trials
Vulvar Cancer Clinical Trial
Updated: 4/24/2013
Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.
Status: Enrolling
Updated: 4/24/2013
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Updated: 6/5/2007
Acupuncture for the Treatment of Phantom Limb and Residual Limb Pain After Amputation
Status: Enrolling,
Phase
I
Updated: 6/5/2007
Click here to add this to my saved trials
Unruptured Brain Arteriovenous Malformation Clinical Trial
Updated: 11/2/2012
A Randomized Trial of Unruptured Brain AVMs
Status: Enrolling
Updated: 11/2/2012
Click here to add this to my saved trials
Unruptured Brain Arteriovenous Malformation Clinical Trial
Updated: 11/2/2012
A Randomized Trial of Unruptured Brain AVMs
Status: Enrolling
Updated: 11/2/2012
Click here to add this to my saved trials
Unruptured Brain Arteriovenous Malformation Clinical Trial
Updated: 11/2/2012
A Randomized Trial of Unruptured Brain AVMs
Status: Enrolling
Updated: 11/2/2012
Click here to add this to my saved trials
Unruptured Brain Arteriovenous Malformation Clinical Trial
Updated: 11/2/2012
A Randomized Trial of Unruptured Brain AVMs
Status: Enrolling
Updated: 11/2/2012
Click here to add this to my saved trials
Unruptured Brain Arteriovenous Malformation Clinical Trial
Updated: 11/2/2012
A Randomized Trial of Unruptured Brain AVMs
Status: Enrolling
Updated: 11/2/2012
Click here to add this to my saved trials
Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial
Updated: 1/9/2014
Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment
Status: Enrolling,
Phase
II
Updated: 1/9/2014
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 4/9/2010
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Status: Enrolling
Updated: 4/9/2010
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 7/22/2009
Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer
Status: Enrolling
Updated: 7/22/2009
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 3/23/2009
Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders
Status: Enrolling
Updated: 3/23/2009
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 10/14/2010
Depression Screening in Patients With Lung Cancer
Status: Enrolling
Updated: 10/14/2010
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
Updated: 6/3/2011
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
Updated: 6/3/2011
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
Updated: 6/3/2011
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
Updated: 6/3/2011
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
Updated: 6/3/2011
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Benign Prostatic Hyperplasia (BPH) Clinical Trial
Updated: 6/3/2011
PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Status: Enrolling
Updated: 6/3/2011
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
Updated: 2/12/2007
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
Status: Enrolling,
Phase
II
Updated: 2/12/2007
Click here to add this to my saved trials